Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients

References

• NieschlagE, SwerdloffR, BehreHM, GoorenLJ, KaufmanJM, LegrosJJ, LunenfeldB, MorleyJE, SchulmanC, WangC, Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2005;8:56–58.
   PubMedGoogle Scholar
• MoralesA, TenoverJL. Androgen deficiency in the aging male: when, who, and how to investigate and treat. Urol Clin N Am 2002;29:975–982.
   PubMed Web of Science ®Google Scholar
• LunenfeldB, SaadF, HoeslCE. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale. Aging Male 2005;8:59–74.
   PubMedGoogle Scholar
• LunenfeldB, NieschlagE. Testosterone therapy in the aging male. Aging Male 2007;10:139–153.
   PubMed Web of Science ®Google Scholar
• WangCM, NieschlagE, SwerdloffRS, BehreH, HellstromWJ, GoorenLJ, KaufmanJM, LegrosJJ, LunenfeldB, MoralesA, ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2009;12:5–12.
   PubMed Web of Science ®Google Scholar
• AmanoT, ImaoT, TakemaeK, IwamotoT, YamakawaK, BabaK, NakanomeM, SugimoriH, TanakaT, YoshidaK, Profile of serum testosterone levels after application of testosterone ointment (Glowmin) and its clinical efficacy in late-onset hypogonadism patients. J Sex Med 2008;5:1727–1736.
   PubMed Web of Science ®Google Scholar
• ShiriR, HakkinenJT, HakamaM, HuhtalaH, AuvinenA, TammelaTL. Koskimaki J. Effect of lower urinary tract symptoms on the incidence of erectile dysfunction. J Urol 2005;174:205–209.
   PubMed Web of Science ®Google Scholar
• El-SakkaAI. Lower urinary tract symptoms in patients with erectile dysfunction: analysis of risk factors. J Sex Med 2006;3:144–149.
   PubMed Web of Science ®Google Scholar
• RhodenEL, RiednerCE, FornariA, FuchsSC, RibeiroER. Evaluation of the association between lower urinary tract symptoms and erectile dysfunction, considering its multiple risk factors. J Sex Med 2008;5:2662–2668.
   PubMed Web of Science ®Google Scholar
• MorantS, BloomfieldG, VatsV, ChappleC. Increased sexual dysfunction in men with storage and voiding lower urinary tract symptoms. J Sex Med 2009;6:1103–1110.
   PubMed Web of Science ®Google Scholar
• MariappanP, ChongWL. Prevalence and correlations of lower urinary tract symptoms, erectile dysfunction and incontinence in men from a multiethnic Asian population: Results of a regional population-based survey and comparison with industrialized nations. BJU Int 2006;98:1264–1268.
   PubMed Web of Science ®Google Scholar
• AmanoT, ImaoT, TakemaeK. Lower urinary tract symptom in patients with late-onset hypogonadism. Jpn J Impotence Res 2009;24:359–365.
   Google Scholar
• Japan Urological Association/Japan Men's Health Medical Association. Clinical guideline for late-onset hypogonadism (LOH). Tokyo, Japan: KK Jiho; 2007. pp 2–28.
   Google Scholar
• HeinemannLAJ, ZimmermannT, VermeulenA, ThielC, Hummel. A new ‘aging males’ symptoms' rating scale. Aging Male 1999;2:105–114.
   Google Scholar
• RosenRC, CappelleriJC, SmithMD, LipskyJ, PenaBM. Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319–326.
   PubMed Web of Science ®Google Scholar
• FukuharaS, WareJE, KosinskiM, WadaS, GandekB. Psychometric and clinical tests of validity of the Japanese SF-36 Healthy Survey. J Clin Epidemiol 1998;51:1045–1053.
   PubMed Web of Science ®Google Scholar
• KarazindiyanogluS, CayanS. The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male 2008;11:146–149.
   PubMed Web of Science ®Google Scholar
• KalinchenkoS, VishnevskyEL, KovalAN, MskhalayaGJ, SaadF. Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study. Aging Male 2008;11:57–61.
   PubMed Web of Science ®Google Scholar
• HaiderA, GoorenLJ, PadungtodP, SaadF. Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalization of plasma testosterone levels in hypogonadal elderly men. Andrologia 2009;41:7–13.
   PubMed Web of Science ®Google Scholar
• TakaoT, TsujimuraA, NakayamaJ, MatsuokaM, MiyagawaY, TakadaS, NonomuraN, OkuyamaA. Lower urinary tract symptoms after hormone replacement therapy in Japanese patients with late-onset hypogonadism: a preliminary report. Int J Urol 2009;16:212–214.
   Google Scholar
• McVaryK. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int 2006;97 (suppl 2):23–28.
   PubMedGoogle Scholar
• TinelH, Stelte-LudwigB, HutterJ, SandnerP. Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms. BJI Int 2006;98:1259–1263.
   PubMed Web of Science ®Google Scholar
• MatsumotoS, HanaiT, UemuraH, LevinRM. Effects of chronic treatment with Vardenafil, a phosphodiesterase 5 inhibitor, on female rat bladder in a partial bladder outlet obstruction model. BJU Int 2009;103:987–990.
   Google Scholar
• SairamK, KulinskayaE, McnicholasTA, BousteadGB, HanburyDC. Sildenafil influences lower urinary tract symptoms. BJU Int 2002;90:836–839.
   PubMed Web of Science ®Google Scholar
• MulhallJP, GuhringP, ParkerM, HoppsC. Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction. J Sex Med 2006;3:662–667.
   PubMed Web of Science ®Google Scholar
• GacciM, Del PopoloG, MacchiarellaA, CelsoM, VittoriG, LapiniA, SerniS, SandnerP, MaggiM, CariniM. Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study. J Urol 2007;178:2040–2044.
   PubMedGoogle Scholar
• McVaryKT, RoehrbornCG, KaminetskyJC, AuerbachSM, WachsB, YoungJM, EslerA, SidesGD, DenesBS. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2007;177:1401–1407.
   PubMed Web of Science ®Google Scholar
• LiguoriG, TrombettaC, De GiorgiG, PomaraG, MaioG, VecchioD, OcelloG, OllandiniG, BucciS, BelgranoE. Efficacy and safety of combined oral therapy with tadalafil and alfuzosin: an integrated approach to the management of patients with lower urinary tract symptoms and erectile dysfunction. Preliminary report. J Sex Med 2009; 6:544–552.
   PubMed Web of Science ®Google Scholar
• YassinAA, El-SakkaAI, SaadF, GoorenLJG. Lower urinary-tract symptoms and testosterone in elderly men. World J Urol 2008;26:359–364.
   PubMed Web of Science ®Google Scholar
• IrwinDE, MilsomI, ReillyK, HunskaarS, KoppZ, HerschomS, CoyneKS, KelleherCJ, ArtibaniW, AbramsP. Overactive bladder is associated with erectile dysfunction and reduced sexual quality of life in men. J Sex Med 2008;5:2904–2910.
   PubMed Web of Science ®Google Scholar
• BraunMH, SommerF, HauptG, MathersMJ, ReifenrathB, EngelmannUH. Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical “Aging Male” symptoms? Results of the “Cologne Male Survey”. Eur Urol 2003;44:588–594.
   PubMed Web of Science ®Google Scholar
• PonholzerA, TemmlC, ObermayrR, MadersbacherS. Association between lower urinary tract symptoms and erectile dysfunction. Urology 2004;64:772–776.
   PubMed Web of Science ®Google Scholar
• FrankelSJ, DonovanJL, PetersTI, AbramsP, DabhoiwalaNF, OsawaD, LinAT. Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol 1998;51:677–685.
   PubMed Web of Science ®Google Scholar
• AslanG, CavusE, KarasH, OnerO, DuranF, EsenA. Association between lower urinary tract symptoms and erectile dysfunction. Arch Androl 2006;52:155–162.
   PubMed Web of Science ®Google Scholar
• LeliefeldHH, StoevelaarHJ, McDonnellJ. Sexual function before and after various treatments for symptomatic benign prostate hyperplasia. BJU Int 2002;89:208–213.
   PubMed Web of Science ®Google Scholar
• ShabsighR, CrawfordED, NehraA, SlawinKM. Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review. Int J Impot Res 2009;21:9–23.
   PubMed Web of Science ®Google Scholar
• TenoverJS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992;75:1092–1098.
   PubMed Web of Science ®Google Scholar
• HolmangS, MarinP, LindstedtG, HedelinH. Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men. Prostate 1993;23:99–106.
   PubMed Web of Science ®Google Scholar